These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21253449)

  • 1. Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.
    Gaudio F; Giordano A; Pavone V; Perrone T; Curci P; Pastore D; Delia M; De' Risi C; Spina A; Liso V; Specchia G
    Adv Hematol; 2011; 2011():707542. PubMed ID: 21253449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
    Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
    J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center].
    Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P
    Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable prognosis after late relapse of Hodgkin's disease.
    Garcia-Carbonero R; Paz-Ares L; Arcediano A; Lahuerta J; Bartolome A; Cortes-Funes H
    Cancer; 1998 Aug; 83(3):560-5. PubMed ID: 9690550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome?
    Markovic O; Andjelic B; Tarabar O; Todorovic M; Filipovic B; Stanisavljevic D; Bila J; Antic D; Marisavljevic D; Mihaljevic B
    J BUON; 2017; 22(2):481-486. PubMed ID: 28534373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Relapses in Hodgkin's Disease: Are They a Distinct Entity?
    Young GA; Perkins AC; Iland HJ; Vincent PC; Kulkarni A
    Leuk Lymphoma; 1991; 4(5-6):363-9. PubMed ID: 27467669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
    Longo DL; Duffey PL; Young RC; Hubbard SM; Ihde DC; Glatstein E; Phares JC; Jaffe ES; Urba WJ; DeVita VT
    J Clin Oncol; 1992 Feb; 10(2):210-8. PubMed ID: 1732422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of localized non-Hodgkin's lymphomas of the head and neck.
    Ruijs CD; Dekker AW; van Kempen-Harteveld ML; van Baarlen J; Hordijk GJ
    Cancer; 1994 Jul; 74(2):703-7. PubMed ID: 8033051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The incidence and treatment of the first relapse in children with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Bogusławska-Jaworska J; Pisarek J; Raś M; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Matysiak M; Newecka-Samól T
    Med Wieku Rozwoj; 2000; 4(1 Suppl 2):73-84. PubMed ID: 12021465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
    Tura S; Mandelli F; Mazza P; Pileri S; Gherlinzoni F; Bocchia M; Zinzani PL; Fiacchini M; Martelli M; Papa G
    Leukemia; 1991; 5 Suppl 1():74-8. PubMed ID: 1716338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas.
    Nückel H; Dürig J; Dührsen U
    Ann Hematol; 2003 Aug; 82(8):481-486. PubMed ID: 12910375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease: summary of twenty years' experience.
    Mazza P; Bocchia M; Zinzani PL; Fiacchini M; Gherlinzoni F; Bandini G; Bendandi M; Frezza GP; Neri S; Barbieri E
    Haematologica; 1992; 77(6):487-93. PubMed ID: 1283856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapse among patients treated for Hodgkin's disease.
    Herman TS; Hoppe RT; Donaldson SS; Cox RS; Rosenberg SA; Kaplan HS
    Ann Intern Med; 1985 Mar; 102(3):292-7. PubMed ID: 3970468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.